What is the share price of Anuh Pharma Ltd (ANUHPHR) today?
The share price of ANUHPHR as on 29th May 2026 is ₹76.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Anuh Pharma Ltd (ANUHPHR) share?
The past returns of Anuh Pharma Ltd (ANUHPHR) share are- Past 1 week: -1.81%
- Past 1 month: -8.90%
- Past 3 months: -1.37%
- Past 6 months: -4.84%
- Past 1 year: -28.69%
- Past 3 years: N/A%
- Past 5 years: -31.71%
What are the peers or stocks similar to Anuh Pharma Ltd (ANUHPHR)?
The peers or stocks similar to Anuh Pharma Ltd (ANUHPHR) include:What is the dividend yield % of Anuh Pharma Ltd (ANUHPHR) share?
The current dividend yield of Anuh Pharma Ltd (ANUHPHR) is 1.97.What is the market cap of Anuh Pharma Ltd (ANUHPHR) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Anuh Pharma Ltd (ANUHPHR) is ₹762.70 Cr as of 29th May 2026.What is the 52 week high and low of Anuh Pharma Ltd (ANUHPHR) share?
The 52-week high of Anuh Pharma Ltd (ANUHPHR) is ₹114.90 and the 52-week low is ₹67.What is the PE and PB ratio of Anuh Pharma Ltd (ANUHPHR) stock?
The P/E (price-to-earnings) ratio of Anuh Pharma Ltd (ANUHPHR) is 18.58. The P/B (price-to-book) ratio is 2.34.Which sector does Anuh Pharma Ltd (ANUHPHR) belong to?
Anuh Pharma Ltd (ANUHPHR) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Anuh Pharma Ltd (ANUHPHR) shares?
You can directly buy Anuh Pharma Ltd (ANUHPHR) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Anuh Pharma Ltd
ANUHPHR Share Price
NSE₹76.100.74% (-0.57)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ANUHPHR Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ANUHPHR Performance & Key Metrics
ANUHPHR Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 18.58 | 2.34 | 1.97% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.72 | 6.24 | 0.47% |
ANUHPHR Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ANUHPHR Company Profile
Anuh Pharma Ltd specializes in manufacturing and selling active pharmaceutical ingredients and corticosteroids for various therapeutic applications.
SUNPHARMA
PE Ratio
37.61
37.61
1Y Return
5.85%
5.85%
Buy Reco %
93.75
93.75
TORNTPHARM
PE Ratio
69.82
69.82
1Y Return
39.53%
39.53%
Buy Reco %
81.48
81.48
CIPLA
PE Ratio
29.17
29.17
1Y Return
5.14%
5.14%
Buy Reco %
62.86
62.86
DRREDDY
PE Ratio
25.87
25.87
1Y Return
4.43%
4.43%
Buy Reco %
51.52
51.52
ZYDUSLIFE
PE Ratio
21.52
21.52
1Y Return
16.54%
16.54%
Buy Reco %
53.57
53.57
ANUHPHR Forecast
ANUHPHR Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ANUHPHR
ANUHPHR
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ANUHPHR Income Statement
ANUHPHR Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 175.76 | 166.71 | 141.63 | 169.35 | 160.45 | 199.54 | 189.87 | 186.86 | 198.97 | 200.86 | ||||||||||
Operating & Other expenses | 148.11 | 144.67 | 127.34 | 149.07 | 144.72 | 179.47 | 176.19 | 174.00 | 178.06 | 182.23 | ||||||||||
EBITDA | 27.65 | 22.04 | 14.29 | 20.28 | 15.73 | 20.07 | 13.68 | 12.86 | 20.91 | 18.63 | ||||||||||
| Depreciation/Amortization | 2.20 | 2.23 | 1.88 | 1.92 | 2.18 | 2.76 | 2.52 | 2.86 | 3.00 | 3.00 | ||||||||||
| PBIT | 25.45 | 19.81 | 12.41 | 18.36 | 13.55 | 17.31 | 11.16 | 10.00 | 17.91 | 15.63 | ||||||||||
| Interest & Other Items | 0.14 | 0.10 | 0.14 | 0.16 | 0.28 | 0.03 | 0.21 | 0.08 | 0.08 | 0.11 | ||||||||||
| PBT | 25.31 | 19.71 | 12.27 | 18.20 | 13.27 | 17.28 | 10.95 | 9.92 | 17.83 | 15.52 | ||||||||||
| Taxes & Other Items | 6.19 | 4.36 | 2.76 | 3.15 | 2.92 | 4.83 | 2.65 | 2.31 | 4.37 | 3.84 | ||||||||||
| Net Income | 19.12 | 15.35 | 9.51 | 15.05 | 10.35 | 12.45 | 8.30 | 7.61 | 13.46 | 11.68 | ||||||||||
| EPS | 1.91 | 1.53 | 0.95 | 1.50 | 1.03 | 1.25 | 0.83 | 0.76 | 1.34 | 1.17 |
ANUHPHR Company Updates
FY 2026FY 2026
Investor Presentation
May 28PDF
Feb 13PDF
Nov 17PDF
Aug 22PDF
ANUHPHR Stock Peers
ANUHPHR Past Performance & Peer Comparison
ANUHPHR Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Anuh Pharma Ltd | 18.58 | 2.34 | 1.97% |
| Sun Pharmaceutical Industries Ltd | 37.61 | 5.96 | 0.89% |
| Torrent Pharmaceuticals Ltd | 69.82 | 19.67 | — |
| Cipla Ltd | 29.17 | 3.62 | 0.93% |
ANUHPHR Stock Price Comparison
Compare ANUHPHR with any stock or ETFCompare ANUHPHR with any stock or ETF
ANUHPHR
ANUHPHR Holdings
ANUHPHR Shareholdings
ANUHPHR Promoter Holdings Trend
ANUHPHR Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ANUHPHR Institutional Holdings Trend
ANUHPHR Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ANUHPHR Shareholding Pattern
ANUHPHR Shareholding Pattern
ANUHPHR Shareholding History
ANUHPHR Shareholding History
Foreign Institutions
Mutual Funds Invested in ANUHPHR
Mutual Funds Invested in ANUHPHR
No mutual funds holding trends are available
Top 1 Mutual Funds holding Anuh Pharma Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.02% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 122/130 (-5) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ANUHPHR stock
smallcases containing ANUHPHR stock
Looks like this stock is not in any smallcase yet.
ANUHPHR Events
ANUHPHR Events
ANUHPHR Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ANUHPHR has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.97%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.71 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ANUHPHR Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ANUHPHR has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.97%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.71 every year
ANUHPHR Upcoming Dividends
ANUHPHR Upcoming Dividends
No upcoming dividends are available
ANUHPHR Past Dividends
ANUHPHR Past Dividends
Cash Dividend
Ex DateEx DateAug 14, 2025
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Aug 14, 2025
Cash Dividend
Ex DateEx DateAug 16, 2024
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateAug 11, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 3, 2022
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Aug 3, 2022
Cash Dividend
Ex DateEx DateAug 17, 2021
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Aug 17, 2021
ANUHPHR Stock News & Opinions
ANUHPHR Stock News & Opinions
Articles & Videos
Corporate
Corporate
Anuh Pharma to conduct AGMAnuh Pharma announced that the 66th Annual General Meeting(AGM) of the company will be held on 12 August 2026.
1 week agoCapital Market - Live
Corporate
Corporate
Board of Anuh Pharma recommends final dividendAnuh Pharma announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.
1 week agoCapital Market - Live
Earnings
Earnings
Anuh Pharma standalone net profit declines 6.26% in the March 2026 quarterNet profit of Anuh Pharma declined 6.26% to Rs 11.68 crore in the quarter ended March 2026 as against Rs 12.46 crore during the previous quarter ended March 2025. Sales rose 2.01% to Rs 202.12 crore in the quarter ended March 2026 as against Rs 198.14 crore during the previous quarter ended March 2025. For the full year,net profit declined 13.31% to Rs 41.05 crore in the year ended March 2026 as against Rs 47.35 crore during the previous year ended March 2025. Sales rose 16.65% to Rs 771.66 crore in the year ended March 2026 as against Rs 661.51 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales202.12198.14 2 771.66661.51 17 OPM %9.849.43 -8.009.21 - PBDT18.5220.05 -8 65.6169.75 -6 PBT15.5217.29 -10 54.2361.01 -11 NP11.6812.46 -6 41.0547.35 -13 Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Corporate
Anuh Pharma to discuss resultsAnuh Pharma will hold a meeting of the Board of Directors of the Company on 20 May 2026.
2 weeks agoCapital Market - Live
Corporate
Corporate
Anuh Pharma clears USFDA inspection of Palghar unitAnuh Pharma announced that its manufacturing facilities located at E-17/3, E-17/4 and E-18, MIDC, Tarapur (Boisar), Palghar, Maharashtra have undergone inspection conducted by the United States Food and Drug Administration (USFDA). The inspection was completed with no Form 483 observations issued.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Earnings
Anuh Pharma standalone net profit rises 30.08% in the December 2025 quarterNet profit of Anuh Pharma rose 30.08% to Rs 13.45 crore in the quarter ended December 2025 as against Rs 10.34 crore during the previous quarter ended December 2024. Sales rose 23.62% to Rs 197.18 crore in the quarter ended December 2025 as against Rs 159.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales197.18159.51 24 OPM %8.529.27 - PBDT20.8215.44 35 PBT17.8213.26 34 NP13.4510.34 30 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Anuh Pharma to convene board meetingAnuh Pharma will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Earnings
Anuh Pharma standalone net profit declines 49.40% in the September 2025 quarterNet profit of Anuh Pharma declined 49.40% to Rs 7.61 crore in the quarter ended September 2025 as against Rs 15.04 crore during the previous quarter ended September 2024. Sales rose 12.01% to Rs 185.88 crore in the quarter ended September 2025 as against Rs 165.95 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales185.88165.95 12 OPM %6.3910.17 - PBDT12.7820.11 -36 PBT9.9218.19 -45 NP7.6115.04 -49 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Anuh Pharma to announce Quarterly ResultAnuh Pharma will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Anuh Pharma standalone net profit declines 12.72% in the June 2025 quarterNet profit of Anuh Pharma declined 12.72% to Rs 8.30 crore in the quarter ended June 2025 as against Rs 9.51 crore during the previous quarter ended June 2024. Sales rose 35.22% to Rs 186.48 crore in the quarter ended June 2025 as against Rs 137.91 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales186.48137.91 35 OPM %5.527.66 - PBDT13.4714.15 -5 PBT10.9512.27 -11 NP8.309.51 -13 Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 16.61%, vs industry avg of 9.86%
Over the last 5 years, market share increased from 0.12% to 0.16%
Over the last 5 years, net income has grown at a yearly rate of 27.04%, vs industry avg of 19.71%